Table 1.
Demographic and clinical characteristics of MS, NMOSD patients, and controls.
| MS | NMOSD | Controls | |
|---|---|---|---|
| Number of subjects | 40 | 13 | 20 |
| Number of eyes enrolled ON eyes Non-ON eyes |
75 30 45 |
20 9 11 |
40 - 40 |
| Age (years), mean ± SD | 35.15 ± 7.47 | 42.08 ± 10.23 | 37.90 ± 11.47 |
| Sex (female/male) | 32/8 | 11/2 | 17/3 |
| Disease duration (years), median (min–max) | 8 (3–32) | 9 (1–33) | - |
| BCVA of enrolled eyes (logMAR), median (min–max) | 0.00 (0.00–0.20) | 0.00 (0.00–2.30) | 0.00 (0.00–0.00) |
BCVA = best-corrected visual acuity; logMAR = the logarithm of the minimum angle of resolution; max = maximum; min = minimum; MS = multiple sclerosis; NMOSD = neuromyelitis optica spectrum disorder; ON = optic neuritis; SD = standard deviation.